1877 — Shanghai Junshi Biosciences Share News
0.000.00%
Last trade - 00:00- HK$15.67bn
- HK$18.79bn
- CNY2.50bn
Brief: Shanghai Junshi Biosciences Says Acceptance Of New Drug Application
Shanghai Junshi's HK shares climb on new drug application plan for cancer treatment
Brief: Shanghai Junshi Biosciences Says As Of Nov 10 Chair Increased A Shares Shareholding
Brief: Shanghai Junshi Biosciences' Q3 Net Loss At 183 Million Yuan
Brief: Shanghai Junshi Biosciences Says Unit Passed FDA On-Site Inspection
Brief: Shanghai Junshi Biosciences Receives FDA Approval Of Investigational New Drug Application For Phase II/III Clinical Study Of JS207
Brief: Shanghai Junshi Biosciences Says JT118 Injection Received Notice Of Approval For Clinical Trial
Brief: Shanghai Junshi Biosciences H1 Net Loss At 412.7 Million Yuan
Brief: Junshi Biosciences' Shareholder To Unload Up To 2% Stake In Co
Shanghai Junshi Biosciences falls on discounted share sale
Brief: Shanghai Junshi Biosciences To Place 41 Mln Shares At HK$25.35 Per H Share
Brief: Shanghai Junshi Biosciences' Unit Received Acceptance Notice Issued By NMPA
Brief: Shanghai Junshi Biosciences Announces Approval Of Supplemental NDA For Ongericimab Injection By NMPA
Brief: Shanghai Junshi Biosciences Says NMPA Approved Supplemental New Drug Application For Toripalimab
Brief: Junshi Biosciences Says Q1 Net Loss At 234.9 Million Yuan
Brief: Junshi Biosciences Says Chairman To Boost Holdings In Co A/H-Shares
Brief: Shanghai Junshi Biosciences Posts FY Loss Attributable Of RMB1,282 Mln
Brief: Shanghai Junshi Biosciences's 2024 Net Loss At 1.3 Billion Yuan
Brief: Shanghai Junshi Biosciences Gets Approval By HSA For Marketing Of Toripalimab